A panel of oncology pharmacists discusses the role of lifileucel in metastatic melanoma and other considerations for using cellular therapy in solid tumors.
Bryant A. Clemons, PharmD, BCOP
Advertisement
Articles by Bryant A. Clemons, PharmD, BCOP
Advertisement
Latest Updated Articles
Optimizing Care for TILs, Cellular Therapy in Melanoma and Solid TumorsPublished: October 6th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Durvalumab/Carboplatin/Etoposide Prove Tolerable in ES-SCLC
2
Tarlatamab Earns Traditional FDA Approval in ES-SCLC
3
FDA Approves Sevabertinib in Non-Squamous NSCLC
4
FDA Accepts NDA for Zidesamtinib in Pretreated Advanced ROS1+ NSCLC
5
